Pepsinogen Assay Findings in Individuals With Gastric Atrophy and Intestinal Metaplasia. [PDF]
Lee SY.
europepmc +1 more source
Canine Gastrinoma with Long-Term Survival After Primary and Repeat Surgeries Using Serial Serum Gastrin Concentrations as an Adjunctive Monitoring Marker: A Report of Two Cases. [PDF]
Takeuchi K +5 more
europepmc +1 more source
Serology and magnetically controlled capsule gastroscopy for opportunistic screening of high-risk events in gastric cancer development: a cross-sectional study. [PDF]
Yang Y +4 more
europepmc +1 more source
Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort. [PDF]
Rossi RE +10 more
europepmc +1 more source
Pharmacological safety and real-world efficacy of the potassium-competitive acid blocker fexuprazan in cardiovascular patients receiving antithrombotic therapy: a prospective cohort study (FEXGARD). [PDF]
Hwang YM, Kim SJ, Yoo M.
europepmc +1 more source
Perspectives on gastric cancer: the central role of gastrin in carcinogenesis by <i>Helicobacter pylori</i>, oxyntic atrophy and drug-induced acid suppression. [PDF]
Waldum H, Fossmark R, Modlin I.
europepmc +1 more source
Oxyntic Gland Intraepithelial T Lymphocytes as Progression Marker of Potential Autoimmune Gastritis. [PDF]
Lenti MV +13 more
europepmc +1 more source
Serum pepsinogen Ⅰ and the pepsinogen Ⅰ/Ⅱ ratio as a non-invasive predictive marker for autoimmune metaplastic atrophic gastritis. [PDF]
Chen C +5 more
europepmc +1 more source
Zastaprazan, a Novel Potassium-Competitive Acid Blocker, for Acid-Related Disorders. [PDF]
Kim GH, Joo DC, Lee MW, Lee BE.
europepmc +1 more source
Relationship between tumor markers and overall survival in small cell lung cancer: a retrospective cohort study. [PDF]
Yan L +6 more
europepmc +1 more source

